viernes, 13 de noviembre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· November 26, 2025

Stock market today: Dow, S&P 500, Nasdaq jump as Wall Street eyes 4th straight win before Thanksgiving

View original at finance.yahoo.com
Stock market today: Dow, S&P 500, Nasdaq jump as Wall Street eyes 4th straight win before Thanksgiving US stocks moved higher on Wednesday, looking to add to a run of wins on the last day of trading before Thanksgiving as Wall Street stays upbeat on an interest-rate cut next month…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Nvidia is putting money into money-losing companies in order for those companies to order their chips

    80% confidence
  • JPMorgan sees S&P 500 reaching 7,500 by end of 2026, potentially surpassing 8,000 if Fed continues cutting rates

    80% confidence
  • Both corporates and governments across the world are racing to invest in AI in search of productivity gains and out of fear of becoming obsolete

    80% confidence
  • Current market conditions set up for punishing oversupply in Q4 2025/Q1 2026, which may necessitate a pronounced step lower in oil prices and OPEC policy pivot

    80% confidence
  • HSBC sees S&P 500 hitting 7,500 by end of 2026

    80% confidence
  • This disruption is unfolding within an already unhealthy K-shaped economy, with AI expected to amplify this polarization even further. The AI 'Wall of Worry' is likely to persist for years to come

    80% confidence
  • JPMorgan sees Brent crude falling to $58 per barrel in 2026, with WTI to trade $4 lower

    80% confidence
  • Nvidia's GPUs are clearly not going anywhere, and potential Google-Meta deal is sign of high AI computing demand but not necessarily big competitive threat

    80% confidence
  • While demand is robust, supply is simply too abundant

    80% confidence
  • The magnitude suggested by market imbalances is unlikely to fully materialize in practice. Adjustments are expected on both the supply and demand sides

    80% confidence
  • Goldman Sachs sees Brent and WTI trading at $56 and $52 respectively in 2026

    80% confidence
  • Despite AI bubble and valuation concerns, current elevated multiples correctly anticipating above-trend earnings growth, an AI capex boom, rising shareholder payouts, and easier fiscal policy

    80% confidence
  • Robinhood is seeing strong customer demand for prediction markets, and we're excited to build on that momentum

    80% confidence
  • The earnings benefit tied to deregulation and broadening AI-related productivity gains remain underappreciated

    80% confidence
  • Nvidia is a generation ahead of rivals in AI chips

    80% confidence
  • Nvidia is not engaged in vendor financing or circular financing schemes

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,995
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,995 hechos verificados con la fuente5,577 documentos fuente archivados
Consulta estos datos → isubstrate.com
Stock market today: Dow, S&P 500, Nasdaq jump as Wall Street eyes 4th straight win before Thanksgiving — Source | Via News | es.VIA.NEWS